{"id":"W2759185183","doi":"10.1200/jco.2013.31.15_suppl.e19147","title":"Phase I/II trial of combination nab-paclitaxel and pemetrexed in advanced solid tumor patients (pts) with emphasis on non-small cell lung cancer (NSCLC).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pemetrexed; Neutropenia; Internal medicine; Oncology; Lung cancer; Febrile neutropenia; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Toxicity; Progressive disease; Clinical endpoint; Chemotherapy; Gastroenterology; Surgery; Clinical trial; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001197481,0.00171077,0.001996679,0.0004769785,0.0003597646,0.0008931468,0.0009538553,0.001281909,0.004541707],"category_scores_gemma":[0.0007778888,0.0006294223,0.0008629732,0.0005133501,0.001015429,0.0007200887,0.0004559491,0.002642844,0.001150317],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008305954,"about_ca_system_score_gemma":0.001388857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007340299,"about_ca_topic_score_gemma":0.001708381,"domain_scores_codex":[0.9997122,0.000151564,0.00001567723,0.00004528638,0.00002647836,0.00004879252],"domain_scores_gemma":[0.9995617,0.00007186497,0.00007936851,0.00003527634,0.00002176735,0.0002299063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7968622,0.0778106,0.006241129,0.0009248964,0.001113069,0.0005754564,0.0003156602,0.002677567,0.03425967,0.000456476,0.005175326,0.07358795],"study_design_scores_gemma":[0.6724431,0.3144058,0.006949929,0.0000319554,0.0002735209,0.0003340667,0.00004601591,0.001177365,0.0017873,0.0002013761,0.002333133,0.00001641703],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893082,0.001420019,0.0005180945,0.0005095798,0.0001535963,0.004834095,0.0009498285,0.0001025713,0.002204116],"genre_scores_gemma":[0.9833567,0.001659061,0.002077587,0.0009551788,0.0001992578,0.00511324,0.002584832,0.00003571576,0.004018332],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004541707,"threshold_uncertainty_score":0.01519346,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03792672054753038,"score_gpt":0.4652624784664411,"score_spread":0.4273357579189107,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}